Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units

INDIANAPOLIS , Aug. 17, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today announced executive leadership changes and the creation of neuroscience and immunology business units. These changes will increase Lilly 's focus on introducing breakthrough new medicines to millions of people